Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine + Losartan vs Chloroquine in COVID-19 Pneumonia
NCT04428268Phase 2Withdrawn
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of losartan in COVID-19 pneumonia (2 arms), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Overall mortality at 28 days. Planned start Mar 2020; status: withdrawn.
02
Drugs
losartan
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04428268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04428268.